Clinical Trials Logo
  1. Home
  2. Neurofibromatoses
  3. NCT02387177

Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype

Neurofibromatoses Clinical Trial

Official title:
Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype

Clinical Trial Summary

The aim of this research is to adapt the NF-specific adult version of the Skype 3RP for use with adolescents, and to test its feasibility, acceptability, and preliminary effect in improving quality of life, and in decreasing stress and psychological distress.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02387177
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase N/A
Start date January 2015
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT04474678 - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!") N/A
Recruiting NCT03406208 - Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing N/A
Completed NCT03513757 - Dexmedetomidine and Propofol for Pediatric MRI Sedation Phase 4
Completed NCT01682811 - Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1) Phase 1
Not yet recruiting NCT03359304 - The Neurofibromatosis-associated Tumor Biobank N/A
Recruiting NCT05779527 - Mindful Parenting - A Single Case Experimental Design Study N/A
Completed NCT01031901 - Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) Phase 1
Recruiting NCT03873610 - Resiliency Training in Adolescents With NF1 and NF2 N/A
Completed NCT01412892 - Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas Phase 2